|
|
 |
|
Viewing report
|
|
|
|
U.S. Tissue Engineering Markets: U.S. Overview, Analysis and Opportunities
Frost & Sullivan, Jan 2012, Pages: 106
The scope of this research service primarily includes tissue engineering products and companies in the wound care and surgery space. Surgery includes cardiovascular, orthopedics, neurology, organ regeneration, hernia repair and breast reconstruction. The dynamic market for tissue engineering is growing steadily over the last decade and continues to grow. A thorough understanding of revenue, procedure and demand analysis is provided for different segments of the study. Tissue engineering market is highly competitive, with more than 50 manufacturers selling hundreds of different products. Since this market is a highly evolving space, there is plenty room for smaller entrepreneurial companies to offer innovative products in the market.
Market Overview
- Technology advancement in the tissue engineering field and better understanding of market needs have been a major boost to growth of this market sector.
- Tissue engineering has shown promise as an important solution to treat tissue and organ failure. It addresses
these problems by implanting natural, synthetic, or semi-synthetic tissues that are fully functional from the start, or that grow into the required functionality.
- Initial efforts have focused on skin equivalents for treating burns, but an increasing number of tissue types are
now being engineered, as well as bio materials and scaffolds used as delivery systems.
- Quality control of the materials used in various surgical applications is a key challenge for the tissue engineering industry.
- End-user ease of use, patient comfort, and recovery times are important features for tissue engineering
materials. Surgeon/physician education will play a major role in extending the adoption rate in this market.
- It is a highly competitive market ranging from major medical device manufacturers to smaller niche technology innovators. Study pertains to the U.S. markets.
- Period: 2008 to 2018.
- Base Year: 2011.
- Forecast Period of Study: 2011 to 2018.
Introduction & Scope
- The scope of this research service primarily includes tissue engineering products that are used to treat chronic wounds, burns, and surgical applications like hernia repair, heart valves, and breast reconstruction.
- The tissue engineering market is marked by extensive R&D. Companies take several years to commercially
launch products in the market. In the 1980s, R&D in tissue engineering and biomaterials took off. As part of this interest, several biomedical engineering departments were established at major universities around the world.
- Wound repair is a key application for tissue engineering products. Although most applications focus on the use of artificial skin to treat burns, different disease conditions are also benefiting.
- A fundamental understanding of tissue differentiation mechanisms that might be harnessed for the development of tissue-engineered products is required to advance treatment of care in the tissue engineering arena.
- Technical advances in the various components of the industry will contribute to market growth. One Component is the availability of biomaterials that act as scaffolds for tissue repair and reconstruction, or for the deposition of engineered tissues and cells preceding implantation.
- For the biological component of tissue engineering, rapid advances are being made in identifying new cell types for use in tissue regeneration. An establishment of a consensus quality control program to ensure that tissue engineering products work and are safe to use is required.
Though companies have been growing organically, growth by mergers and acquisitions has been a trend in this market, with major competitors growing largely through acquisitions of smaller companies.
Major manufacturers in the market are Medtronic, Cook, Lifecell, W. L. Gore, Integra, and others.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
